Luxa's stem cell therapy for dry AMD shows early promise
Luxa Biotechnology said Thursday that its stem cell therapy helped improve vision in a handful of people with a common form of an age-related eye condition. In its lowest dose cohort, the Phase 1/2a study ...
Luxa Biotechnology said Thursday that its stem cell therapy helped improve vision in a handful of people with a common form of an age-related eye condition.
In its lowest dose cohort, the Phase 1/2a study ...
